THE SCIENCE OF BUSINESS. THE BUSINESS OF SCIENCE.
Gemini BioProjects LLC was established in 2002 as a resource to all those engaged in communicating the science of business and the business of science. Our practice blends in-depth understanding of the biosciences and drug development processes with expertise in corporate and marketing communications as well as investor and media relations. This uncommon mix of skills and expertise is paralleled by an uncommon approach to client service. At Gemini BioProjects, we understand that the dynamic environment found in the life science industries leads inevitably to an ebb and flow in our clients’ communications needs. While the practice is able and available to develop and implement a comprehensive suite of communications strategies, our goal is to provide precisely those services that our clients need, when they need them. This flexible approach enables Gemini BioProjects to serve as either the sole provider of external communications support or as part of a team. Our clients can utilize our capabilities for specific projects or to fill an ongoing need. We pride ourselves on our ability to tailor our strategies, services, and fees to match our clients’ needs: No long-term commitments, no minimum fees, nothing unnecessary. We believe that the quality of our work and our commitment to excellence will keep our clients coming back.
OUR CAPABILITIES
Strategic Planning
- Message development
- Positioning
- Developing/implementing communications programs
Writing/Editing
- Press releases/Press kits
- Annual reports
- Corporate fact sheets
- Technology backgrounders
- SEC documents
- Technical documents
- Scientific manuscripts
- By-lined articles
- Web site content
- Corporate presentations
- Marketing materials
Investor/Media Relations
- Contacting/building relationships with members of the financial and media communities
Event Planning
“We have been working with Stephanie for over 10 years and she has helped us write numerous scientific articles. She has always been professional and sharp in her approach to manuscript writing. She is quick to grasp the subject and ask the right questions, which saves time and effort. We wouldn’t have been able to publish as many articles without her help.”
Joseph Saba, MD, Chief Executive Officer, Axios International
“I’ve had the good fortune to partner with Stephanie on a variety of life sciences communications projects spanning more than 15 years. Whether we’re working together on a one-off project or sustained client engagement, she delivers insightful counsel and sharp, thoughtful copy on time, on budget, and above expectations.”
Hal Mackins, Senior Partner, Torch Communications
OUR AREAS OF EXPERTISE
Technologies
- Gene/cell therapy
- Gene editing/functional genomics
- Small-molecule drugs
- Monoclonal antibodies
- Therapeutic proteins
- Cancer vaccines
- Immunotherapies
Disease Indications
- Oncology
- Autoimmune diseases
- Inherited retinal diseases
- Cardiovascular disease
- Viral infectious diseases
- Genetic disorders
- Gastrointestinal disorders
- Coagulation and hemostasis
- Diabetes and metabolic disorders
Corporate Issues
- SEC disclosure/Reg FD
- Crisis management
- Image management
- Employee communications
- Outreach to patient advocacy groups
Stephanie H. Seiler, Ph.D.
Gemini BioProjects LLC
2729 233rd Street SW, Brier, WA 98036
206-713-0124
stephanie@geminibioprojectsllc.com